Heron Therapeutics
HRTX
#10061
Rank
A$0.10 B
Marketcap
A$0.55
Share price
30.40%
Change (1 day)
-67.63%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): A-$1.77

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.28. In 2022 the company made an earnings per share (EPS) of A-$2.51 an increase over its 2021 EPS that were of A-$3.26.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$1.77-29.4%
2022A-$2.51-23.11%
2021A-$3.26-10%
2020A-$3.62-0%
2019A-$3.621.21%
2018A-$3.58-32.7%
2017A-$5.32-19.34%
2016A-$6.5954.76%
2015A-$4.261.73%
2014A-$4.19-16.23%
2013A-$5.0091.67%
2012A-$2.61-31.45%
2011A-$3.80-27.06%
2010A-$5.21-43.75%
2009A-$9.27-57.33%
2008A-$21.73-82.92%
2007A-$127.1720.61%
2006A-$105.44175.76%
2005A-$38.24-21.43%
2004A-$48.67100%
2003A-$24.33-38.24%
2002A-$39.40161.54%
2001A-$15.06-106.46%
2000A$233.042051.55%
1999A$10.83839.73%
1998A$1.15-105.48%
1997A-$21.05-88.16%
1996A-$177.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
A-$1.78 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
A$0.51-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$14.50-5,368.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$0.58-310.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
A-$4.29 1,457.89%๐Ÿ‡บ๐Ÿ‡ธ USA